Smith, Moore & Co. Bio Sig Technologies, Inc. Transaction History

Smith, Moore & Co.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.4 - $1.39 $3,400 - $11,815	-8,500 Reduced 6.2%	128,675 $63,000
Q2 2023 Aug 11, 2023	BUY	$1.07 - $1.55 $14,552 - $21,080	13,600 Added 11.01%	137,175 $171,000
Q1 2023 May 12, 2023	BUY	$0.42 - $1.4 $12,562 - $41,874	29,910 Added 31.93%	123,575 $140,000
Q4 2022 Feb 13, 2023	BUY	$0.31 - $8.8 $635 - $18,040	2,050 Added 2.24%	93,665 $39,000
Q3 2022 Nov 14, 2022	SELL	$0.56 - $6.98 $6,580 - $82,015	-11,750 Reduced 11.37%	91,615 $59,000
Q2 2022 Aug 12, 2022	SELL	$0.63 - $1.22 $49,108 - $95,099	-77,950 Reduced 42.99%	103,365 $68,000
Q1 2022 May 12, 2022	BUY	$0.99 - $2.44 $247 - $610	250 Added 0.14%	181,315 $209,000
Q4 2021 Feb 08, 2022	BUY	$2.18 - $3.93 $394,721 - $711,585	181,065 New	181,065 $404,000

88.1K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $47.5M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

Stay updated on Smith, Moore & Co. with notifications on news.